Financial IncentivesDecreasing levels of reimbursement and profitability for pharmacies may result in less willingness to stock the company’s products, negatively impacting sales.
Industry PerceptionStigma from medical practitioners could lead to reduced adoption of the company's products, as prescribers and pharmacists are reluctant to include them in their practices and pharmacies.
Regulatory ChallengesHeightened DEA oversight and regulatory uncertainties, especially contradictions with state laws, could pose significant operational challenges for the company.